Replaces deficient growth hormone when an endocrinologist confirms an appropriate diagnosis and establishes a monitoring plan.
HORMONES, ENERGY & VITALITY / PRACTITIONER-GUIDED
Human growth hormone
Somatropin and related growth-hormone products are replacement therapies for confirmed deficiency and other narrow indications—not routine anti-aging, fat-loss or bodybuilding drugs.Create account & prepare for review →Endocrinology review required · A prescription is never guaranteed.
Established for product-specific approved indications; healthy-aging and performance use in people without deficiency is not an approved or proven pathway.
Prescription required; diagnosis- and product-specific FDA indications
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓Symptoms and formal endocrine testing support true growth-hormone deficiency
- ✓Pituitary history and alternative causes have been evaluated
- ✓IGF-1, glucose and adverse effects can be monitored
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- →Pituitary history, provocative testing and IGF-1 context
- →Cancer history, glucose status and intracranial pressure risk
- →Sleep apnea, edema, joint symptoms and interacting hormone deficiencies
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !Active malignancy and several acute critical illnesses are major contraindication or warning contexts.
- !Fluid retention, nerve compression, glucose intolerance and intracranial hypertension can occur.
- !A low-normal IGF-1 or desire for more muscle does not establish adult growth-hormone deficiency.
ORIGINAL SOURCES